Study type

Study topic

DiseaseĀ /health condition

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Disease epidemiology
Effectiveness study (incl. comparative)

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Cohort
Other

Non-interventional study design, other

Observational, Non-interventional Study (Registry)
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(H05AA03) parathyroid hormone
parathyroid hormone

Medical condition to be studied

Hypoparathyroidism
Population studied

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Patients with hypoparathyroidism

Estimated number of subjects

1339
Study design details

Main study objective

To characterize and describe the long-term safety and effectiveness profile of rhPTH(1-84) treatment in patients with chronic hypoparathyroidism under conditions of routine clinical practice.

Outcomes

- Hypoparathyroidism Laboratory Test - Renal Function - Incidence Rate of the Renal Events - Incidence Rate of the Soft Tissue Calcifications (site) - Incidence Rate of the Cataract - Incidence Rate of the Bone Fractures (site) - Incidence Rate of the Cardiovascular Events - Number of Participants With Adverse Events and Serious Adverse Events, - Health-related Quality of Life (HRQoL) - Disease-specific Patient-reported Outcome Measures - Rate of Hospitalization/Emergency Room (ER) Visits

Data analysis plan

Data will primarily be summarized with descriptive statistics comprising the number of observations (n), mean, standard deviation, median, minimum, and maximum for continuous variables, and counts and percentages for categorical variables. Person-years of follow-up and incidence rates of prospective events will be calculated.